When you’re talking about medical device cybersecurity, of course. According to a recent study by Deloitte, more than 35% of professionals in the Internet of Things-connected medical device ecosystem say their organizations have experienced a cybersecurity incident in the past year. What the #&%$ is an “incident?” Want to hear something scary? Of course you do. 27% of respondents indicated they “don’t know.” So, when you do the math, it means 45% of respondents who had knowledge, indicated they had an incident. Stupid math. So, we have that going for us, which is nice. In researching this article, we found a statement you might find amusing: “A little over one-third of respondents (30.1%) stated….” Nope.
The current process we use for determining the boundary between cancerous and healthy cells during surgery—frozen section procedure—has been around for over 100 years. Let that sink in. While we’re sure there have been vast improvements in optimizing the procedure in the past century, it still takes about 30 minutes to prepare and analyze a section. That’s a lot of extra time to stay under for surgery. Well researchers at The University of Texas at Austin decided they wanted to make that time faster—about 150 times faster. Their device, the MasSpec Pen, is reportedly able to make the analysis within 10 seconds, is more accurate than FSP, and allows for more precision during tissue removal. Nice work, Longhorns.
People with Type 1 diabetes could soon be saying goodbye to sticking their fingers to check blood sugar levels. This news comes from a study among children with Type 1 diabetes conducted by the University of Virginia, that tested how well an artificial pancreas developed by the school performed at managing insulin and glucose levels against the patient’s home routine. The platform, which is controlled using a smartphone, uses algorithms that wirelessly link to a blood-sugar monitor and insulin pump worn by the patient, as well as to a remote-monitoring site. The children using the device averaged more time within the target blood-sugar range without an increase in hypoglycemia than those without. Also, probably no need to worry about getting kids to check their phones.